Qiagen NV (QGEN) PT Raised to $50 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts QGEN Hot Sheet
Price: $50.38 --0%
Rating Summary:
12 Buy, 19 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 11 | New: 7
Rating Summary:
12 Buy, 19 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 11 | New: 7
Join SI Premium – FREE
UBS analyst John Sourbeer raised the price target on Qiagen NV (NYSE: QGEN) to $50.00 (from $48.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Duolingo Inc. (DUOL) PT Raised to $165 at Needham
- Red Rock Resorts (RRR) PT Lowered to $70 at Citizens - 'Investors View Result as a Miss'
- Amgen (AMGN) PT Raised to $460 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
